{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:12:26Z","timestamp":1794561146860,"version":"4.9.1"},"reference-count":111,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"unspecified","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","award":["A334000"],"award-info":[{"award-number":["A334000"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2026,7,31]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major global health burden and fibrosis stage remains the principal determinant of liver-related and overall outcomes. As management increasingly relies on non-invasive risk stratification and treatment monitoring, MRI has become an important quantitative platform for liver assessment. This narrative review summarises the technical foundations and guideline-based applications of MRI in MASLD. MRI proton density fat fraction quantifies hepatic steatosis, magnetic resonance elastography measures liver stiffness as a marker of fibrosis and corrected T1 provides information on fibroinflammatory activity. MRI-based composite models, including magnetic resonance elastography combined with the fibrosis-4 index and MRI-aspartate aminotransferase score, integrate imaging and biochemical biomarkers for risk assessment. Current international guidelines generally recommend a stepwise pathway beginning with high-risk case-finding and blood-based fibrosis assessment, followed by elastography or other imaging-based tests when indicated. MRI is not routinely recommended for universal first-line screening but may add value in indeterminate or discordant cases, suspected advanced fibrosis or at-risk metabolic dysfunction-associated steatohepatitis, treatment selection and longitudinal monitoring. By integrating technical evidence with recommendations from major international societies, this review provides a practical framework for the use of MRI across the MASLD care pathway.<\/jats:p>","DOI":"10.1136\/bmjgast-2026-002471","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:50:18Z","timestamp":1787914218000},"page":"e002471","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["MRI in MASLD: technical foundations and guideline-based applications"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2681-1613","authenticated-orcid":false,"given":"Jun","family":"Pu","sequence":"first","affiliation":[{"name":"Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Ping","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"2026082803500992000_13.1.e002471.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"2026082803500992000_13.1.e002471.2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/j.gastro.2025.02.044","article-title":"Global consensus recommendations for metabolic dysfunction-associated steatotic liver disease and steatohepatitis","volume":"169","author":"Younossi","year":"2025","journal-title":"Gastroenterology"},{"key":"2026082803500992000_13.1.e002471.3","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323"},{"key":"2026082803500992000_13.1.e002471.4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29085"},{"key":"2026082803500992000_13.1.e002471.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.07.027"},{"key":"2026082803500992000_13.1.e002471.6","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001112"},{"key":"2026082803500992000_13.1.e002471.7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701"},{"key":"2026082803500992000_13.1.e002471.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.01.042"},{"key":"2026082803500992000_13.1.e002471.9","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101547","article-title":"Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"51","author":"Cao","year":"2022","journal-title":"EClinicalMedicine"},{"key":"2026082803500992000_13.1.e002471.10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jmri.22580","article-title":"Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy","volume":"34","author":"Reeder","year":"2011","journal-title":"Magnetic Resonance Imaging"},{"key":"2026082803500992000_13.1.e002471.11","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.23731"},{"key":"2026082803500992000_13.1.e002471.12","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.21090"},{"key":"2026082803500992000_13.1.e002471.13","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.1622"},{"key":"2026082803500992000_13.1.e002471.14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/mrm.25054","article-title":"Liver fat quantification using a multi-step adaptive fitting approach with multi-echo GRE imaging","volume":"72","author":"Zhong","year":"2014","journal-title":"Magn Reson Med"},{"key":"2026082803500992000_13.1.e002471.15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26455"},{"key":"2026082803500992000_13.1.e002471.16","doi-asserted-by":"publisher","DOI":"10.1126\/science.7569924"},{"key":"2026082803500992000_13.1.e002471.17","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231092","article-title":"Repeatability of MRI biomarkers in nonalcoholic fatty liver disease: the NIMBLE Consortium","volume":"309","author":"Fowler","year":"2023","journal-title":"Radiology"},{"key":"2026082803500992000_13.1.e002471.18","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00330-015-3949-z","article-title":"Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis","volume":"26","author":"Singh","year":"2016","journal-title":"Eur Radiol"},{"key":"2026082803500992000_13.1.e002471.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.044"},{"key":"2026082803500992000_13.1.e002471.20","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.cgh.2020.12.016","article-title":"Direct comparison of US and MR elastography for staging liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"20","author":"Imajo","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026082803500992000_13.1.e002471.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.09.002"},{"key":"2026082803500992000_13.1.e002471.22","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.575843","article-title":"Correlations between MRI biomarkers PDFF and cT1 with histopathological features of non-alcoholic steatohepatitis","volume":"11","author":"Dennis","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026082803500992000_13.1.e002471.23","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.cgh.2021.09.041","article-title":"Clinical utility of magnetic resonance imaging biomarkers for identifying nonalcoholic steatohepatitis patients at high risk of progression: a multicenter pooled data and meta-analysis","volume":"20","author":"Andersson","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026082803500992000_13.1.e002471.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.046"},{"key":"2026082803500992000_13.1.e002471.25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MOL.0000000000000720","article-title":"Liver fat storage pathways: methodologies and dietary effects","volume":"32","author":"Roumans","year":"2021","journal-title":"Curr Opin Lipidol"},{"key":"2026082803500992000_13.1.e002471.26","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/hep.28390","article-title":"Noninvasive fatty liver markers predict liver disease mortality in the U.S. population","volume":"63","author":"Unalp\u2010Arida","year":"2016","journal-title":"Hepatology"},{"key":"2026082803500992000_13.1.e002471.27","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-198507010-00002"},{"key":"2026082803500992000_13.1.e002471.28","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/30\/4\/008"},{"key":"2026082803500992000_13.1.e002471.29","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2372040539"},{"key":"2026082803500992000_13.1.e002471.30","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.153.1.6089263"},{"key":"2026082803500992000_13.1.e002471.31","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.D800010-JLR200"},{"key":"2026082803500992000_13.1.e002471.32","doi-asserted-by":"crossref","unstructured":"Bydder M , Hamilton G , de Rochefort L , et al . Sources of systematic error in proton density fat fraction (PDFF) quantification in the liver evaluated from magnitude images with different numbers of echoes. NMR Biomed 2018;31. doi:10.1002\/nbm.3843","DOI":"10.1002\/nbm.3843"},{"key":"2026082803500992000_13.1.e002471.33","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.5274","article-title":"Prediction of MRI R2* relaxometry in the presence of hepatic steatosis by Monte Carlo simulations","volume":"38","author":"Ma","year":"2025","journal-title":"NMR Biomed"},{"key":"2026082803500992000_13.1.e002471.34","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.crad.2020.07.031","article-title":"Differences in multi-echo chemical shift encoded MRI proton density fat fraction estimation based on multifrequency fat peaks selection in non-alcoholic fatty liver disease patients","volume":"75","author":"Mart\u00ed-Aguado","year":"2020","journal-title":"Clin Radiol"},{"key":"2026082803500992000_13.1.e002471.35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1148\/radiol.2017161786","article-title":"Proton density fat fraction measurements at 1.5- and 3-T hepatic MR imaging: same-day agreement among readers and across two imager manufacturers","volume":"284","author":"Serai","year":"2017","journal-title":"Radiology"},{"key":"2026082803500992000_13.1.e002471.36","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/HEP.0000000000000895","article-title":"Ultrasound-based steatosis grading system using 2D-attenuation imaging: an individual patient data meta-analysis with external validation","volume":"81","author":"Hobeika","year":"2025","journal-title":"Hepatology"},{"key":"2026082803500992000_13.1.e002471.37","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020191152"},{"key":"2026082803500992000_13.1.e002471.38","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.223146","article-title":"The future is beyond bright: the evolving role of quantitative US for fatty liver disease","volume":"309","author":"Ozturk","year":"2023","journal-title":"Radiology"},{"key":"2026082803500992000_13.1.e002471.39","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70123","article-title":"Noninvasive quantification of hepatic steatosis using ultrasound-derived fat fraction (CHESS2303): a prospective multicenter study","volume":"6","author":"Huang","year":"2025","journal-title":"MedComm"},{"key":"2026082803500992000_13.1.e002471.40","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1007\/s00330-024-11119-2","article-title":"Comparing ultrasound-derived fat fraction and MRI-PDFF for quantifying hepatic steatosis: a real-world prospective study","volume":"35","author":"Qi","year":"2025","journal-title":"Eur Radiol"},{"key":"2026082803500992000_13.1.e002471.41","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.23.30775","article-title":"Ultrasound-derived fat fraction for hepatic steatosis assessment: prospective study of agreement with MRI PDFF and sources of variability in a heterogeneous population","volume":"222","author":"Kubale","year":"2024","journal-title":"AJR Am J Roentgenol"},{"key":"2026082803500992000_13.1.e002471.42","doi-asserted-by":"crossref","first-page":"111931","DOI":"10.1016\/j.ejrad.2025.111931","article-title":"Comparison of ultrasound to MR and histological methods for liver fat quantification","volume":"183","author":"Gottfriedova","year":"2025","journal-title":"Eur J Radiol"},{"key":"2026082803500992000_13.1.e002471.43","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1016\/j.acra.2025.03.008","article-title":"Performance of magnetic resonance imaging and ultrasound for identifying the different degrees of hepatic steatosis: a systematic review and meta-analysis","volume":"32","author":"Wu","year":"2025","journal-title":"Acad Radiol"},{"key":"2026082803500992000_13.1.e002471.44","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1007\/s00330-024-11001-1","article-title":"Evaluation of MRI proton density fat fraction in hepatic steatosis: a systematic review and meta-analysis","volume":"35","author":"Azizi","year":"2025","journal-title":"Eur Radiol"},{"key":"2026082803500992000_13.1.e002471.45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255768","article-title":"Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard","volume":"16","author":"Tran","year":"2021","journal-title":"PLoS One"},{"key":"2026082803500992000_13.1.e002471.46","doi-asserted-by":"publisher","DOI":"10.1177\/0284185115580488"},{"key":"2026082803500992000_13.1.e002471.47","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.21037\/qims-22-393","article-title":"The spectrum of magnetic resonance imaging proton density fat fraction (MRI-PDFF), magnetic resonance spectroscopy (MRS), and two different histopathologic methods (artificial intelligence vs. pathologist) in quantifying hepatic steatosis","volume":"12","author":"Kim","year":"2022","journal-title":"Quant Imaging Med Surg"},{"key":"2026082803500992000_13.1.e002471.48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2023.100928","article-title":"Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: a meta-analysis","volume":"6","author":"Qadri","year":"2024","journal-title":"JHEP Rep"},{"key":"2026082803500992000_13.1.e002471.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.08.061"},{"key":"2026082803500992000_13.1.e002471.50","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02603-1"},{"key":"2026082803500992000_13.1.e002471.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.025"},{"key":"2026082803500992000_13.1.e002471.52","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3350\/cmh.2023.0384","article-title":"Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: a systematic review and meta-analysis","volume":"30","author":"Hwang","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"2026082803500992000_13.1.e002471.53","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-70242-8","article-title":"Efficacy and safety of Resmetirom, a selective thyroid hormone receptor-\u03b2 agonist, in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis","volume":"14","author":"Suvarna","year":"2024","journal-title":"Sci Rep"},{"key":"2026082803500992000_13.1.e002471.54","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3390\/biomedicines12102328","article-title":"Comparative analysis of resmetirom vs. FGF21 analogs vs. GLP-1 agonists in MASLD and MASH: network meta-analysis of clinical trials","volume":"12","author":"Ayesh","year":"2024","journal-title":"Biomedicines"},{"key":"2026082803500992000_13.1.e002471.55","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(20)30186-2"},{"key":"2026082803500992000_13.1.e002471.56","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2025.12.026","article-title":"Is liver steatosis a disease or the emperor\u2019s new clothes?","volume":"84","author":"Krag","year":"2026","journal-title":"J Hepatol"},{"key":"2026082803500992000_13.1.e002471.57","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.15.14552"},{"key":"2026082803500992000_13.1.e002471.58","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/RMR.0000000000000179","article-title":"Advances and future direction of magnetic resonance elastography","volume":"27","author":"Dong","year":"2018","journal-title":"Top Magn Reson Imaging"},{"key":"2026082803500992000_13.1.e002471.59","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13122208"},{"key":"2026082803500992000_13.1.e002471.60","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1007\/s00330-025-11533-0","article-title":"Concordance of vibration-controlled transient elastography and magnetic resonance elastography for fibrosis staging in patients with metabolic dysfunction-associated steatotic liver disease","volume":"35","author":"Mathur","year":"2025","journal-title":"Eur Radiol"},{"key":"2026082803500992000_13.1.e002471.61","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/HEP.0000000000000262","article-title":"Cost-effectiveness of MRE versus VCTE in staging fibrosis for nonalcoholic fatty liver disease (NAFLD) patients with advanced fibrosis","volume":"77","author":"Sangha","year":"2023","journal-title":"Hepatology"},{"key":"2026082803500992000_13.1.e002471.62","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1007\/s00261-021-03269-4","article-title":"Liver fibrosis assessment: MR and US elastography","volume":"47","author":"Ozturk","year":"2022","journal-title":"Abdom Radiol (NY)"},{"key":"2026082803500992000_13.1.e002471.63","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jhep.2023.04.025","article-title":"An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography","volume":"79","author":"Liang","year":"2023","journal-title":"J Hepatol"},{"key":"2026082803500992000_13.1.e002471.64","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1148\/radiol.14132592","article-title":"MR elastography for the assessment of hepatic fibrosis in patients with chronic hepatitis B infection: does histologic necroinflammation influence the measurement of hepatic stiffness?","volume":"273","author":"Shi","year":"2014","journal-title":"Radiology"},{"key":"2026082803500992000_13.1.e002471.65","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.dld.2024.04.031","article-title":"Inflammation activity affects liver stiffness measurement by magnetic resonance elastography in MASLD","volume":"56","author":"Wei","year":"2024","journal-title":"Digestive and Liver Disease"},{"key":"2026082803500992000_13.1.e002471.66","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2017160622"},{"key":"2026082803500992000_13.1.e002471.67","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13244-024-01652-5","article-title":"Viscoelastic parameters derived from multifrequency MR elastography for depicting hepatic fibrosis and inflammation in chronic viral hepatitis","volume":"15","author":"Wang","year":"2024","journal-title":"Insights Imaging"},{"key":"2026082803500992000_13.1.e002471.68","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/hep.30483","article-title":"The role of three-dimensional magnetic resonance elastography in the diagnosis of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery","volume":"71","author":"Allen","year":"2020","journal-title":"Hepatology"},{"key":"2026082803500992000_13.1.e002471.69","doi-asserted-by":"crossref","first-page":"8408","DOI":"10.1007\/s00330-021-07988-6","article-title":"Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis","volume":"31","author":"Qu","year":"2021","journal-title":"Eur Radiol"},{"key":"2026082803500992000_13.1.e002471.70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep4.1446","article-title":"Multiparametric magnetic resonance elastography improves the detection of NASH regression following bariatric surgery","volume":"4","author":"Allen","year":"2020","journal-title":"Hepatol Commun"},{"key":"2026082803500992000_13.1.e002471.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.04.014"},{"key":"2026082803500992000_13.1.e002471.72","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/jmri.29610","article-title":"Quantitative MRI for monitoring metabolic dysfunction-associated steatotic liver disease: a test\u2013retest repeatability study","volume":"61","author":"Beyer","year":"2025","journal-title":"Magnetic Resonance Imaging"},{"key":"2026082803500992000_13.1.e002471.73","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.06.023"},{"key":"2026082803500992000_13.1.e002471.74","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","article-title":"American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocrine Practice"},{"key":"2026082803500992000_13.1.e002471.75","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cgh.2025.03.003","article-title":"Change in cT1 following interventions in MASLD: a systematic review and meta-analysis","volume":"24","author":"Andersson","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026082803500992000_13.1.e002471.76","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2413258"},{"key":"2026082803500992000_13.1.e002471.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.06.011"},{"key":"2026082803500992000_13.1.e002471.78","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/j.gastro.2022.06.073","article-title":"Liver stiffness on magnetic resonance elastography and the MEFIB index and liver-related outcomes in nonalcoholic fatty liver disease: a systematic review and meta-analysis of individual participants","volume":"163","author":"Ajmera","year":"2022","journal-title":"Gastroenterology"},{"key":"2026082803500992000_13.1.e002471.79","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03654-2"},{"key":"2026082803500992000_13.1.e002471.80","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520"},{"key":"2026082803500992000_13.1.e002471.81","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2024.11.028","article-title":"Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease","volume":"82","author":"Arab","year":"2025","journal-title":"J Hepatol"},{"key":"2026082803500992000_13.1.e002471.82","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2025-100319","article-title":"Metabolic dysfunction and alcohol-associated liver disease (MetALD)","volume":"3","author":"Gao","year":"2025","journal-title":"egastro"},{"key":"2026082803500992000_13.1.e002471.83","doi-asserted-by":"crossref","first-page":"16474","DOI":"10.3748\/wjg.v20.i44.16474","article-title":"Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis?","volume":"20","author":"Sakhuja","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2026082803500992000_13.1.e002471.84","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/apt.18506","article-title":"Head-to-head comparison between phosphatidylethanol versus indirect alcohol biomarkers for diagnosis of MetALD versus MASLD: a prospective study","volume":"61","author":"Tavaglione","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"2026082803500992000_13.1.e002471.85","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jhep.2024.05.042","article-title":"Diagnostic performance of non-invasive tests in patients with MetALD in a health check-up cohort","volume":"81","author":"Oh","year":"2024","journal-title":"J Hepatol"},{"key":"2026082803500992000_13.1.e002471.86","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(24)01545-9","article-title":"WED-200 Prevalence and tissue characteristics of steatotic liver disease subclassifications in the adult UK population using quantitative MRI clinical thresholds: a UK biobank study","volume":"80","author":"Diamond","year":"2024","journal-title":"J Hepatol"},{"key":"2026082803500992000_13.1.e002471.87","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-025-00796-9","article-title":"Utility and cost-effectiveness of LiverMultiScan for MASLD diagnosis: a real-world multi-national randomised clinical trial","volume":"5","author":"Shumbayawonda","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"2026082803500992000_13.1.e002471.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.04.017"},{"key":"2026082803500992000_13.1.e002471.89","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/apt.14469","article-title":"Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease","volume":"47","author":"Eddowes","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2026082803500992000_13.1.e002471.90","doi-asserted-by":"publisher","DOI":"10.3310\/MNJY9014"},{"key":"2026082803500992000_13.1.e002471.91","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2022.0334"},{"key":"2026082803500992000_13.1.e002471.92","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71995-8","article-title":"A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis","volume":"10","author":"Dennis","year":"2020","journal-title":"Sci Rep"},{"key":"2026082803500992000_13.1.e002471.93","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.mri.2021.10.016","article-title":"Free-breathing 3D stack-of-radial MRI quantification of liver fat and R2* in adults with fatty liver disease","volume":"85","author":"Armstrong","year":"2022","journal-title":"Magn Reson Imaging"},{"key":"2026082803500992000_13.1.e002471.94","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3348\/kjr.2024.0862","article-title":"Deep learning-accelerated non-contrast abbreviated liver MRI for detecting malignant focal hepatic lesions: dual-center validation","volume":"26","author":"Park","year":"2025","journal-title":"Korean J Radiol"},{"key":"2026082803500992000_13.1.e002471.95","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.mric.2021.05.003","article-title":"Abbreviated MR protocols for chronic liver disease and liver cancer","volume":"29","author":"Carbonell","year":"2021","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"2026082803500992000_13.1.e002471.96","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2026.01.047"},{"key":"2026082803500992000_13.1.e002471.97","doi-asserted-by":"publisher","DOI":"10.2337\/dci24-0094"},{"key":"2026082803500992000_13.1.e002471.98","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/08465371251357447","article-title":"Part 2: CAR metabolic dysfunction-associated steatotic liver disease working group recommendations for risk stratifying patients with MASLD","volume":"77","author":"Wilson","year":"2026","journal-title":"Can Assoc Radiol J"},{"key":"2026082803500992000_13.1.e002471.99","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2026-002294","article-title":"Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications","volume":"13","author":"Tachi","year":"2026","journal-title":"BMJ Open Gastroenterol"},{"key":"2026082803500992000_13.1.e002471.100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/dom.70545","article-title":"Providing holistic care for patients with metabolic dysfunction-associated steatotic liver disease\/metabolic dysfunction-associated steatohepatitis: Key aspects of clinical assessment and how to develop individualised care plans for surveillance and interventions","volume":"28 Suppl 2","author":"Chen","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"2026082803500992000_13.1.e002471.101","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12072-024-10774-3","article-title":"The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease","volume":"19","author":"Eslam","year":"2025","journal-title":"Hepatol Int"},{"key":"2026082803500992000_13.1.e002471.102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"2026082803500992000_13.1.e002471.103","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2026-002343","article-title":"Liver fibrosis in metabolic dysfunction-associated steatotic liver disease: epidemiology, risk stratification and therapeutics","volume":"13","author":"Li","year":"2026","journal-title":"BMJ Open Gastroenterol"},{"key":"2026082803500992000_13.1.e002471.104","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2025-100196","article-title":"Key takeaways from the updated multidisciplinary European MASLD guidelines","volume":"3","author":"Horn","year":"2025","journal-title":"eGastroenterology"},{"key":"2026082803500992000_13.1.e002471.105","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322976"},{"key":"2026082803500992000_13.1.e002471.106","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jhep.2021.11.012","article-title":"MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis","volume":"76","author":"Noureddin","year":"2022","journal-title":"J Hepatol"},{"key":"2026082803500992000_13.1.e002471.107","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jhep.2022.07.020","article-title":"Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD","volume":"77","author":"Kim","year":"2022","journal-title":"J Hepatol"},{"key":"2026082803500992000_13.1.e002471.108","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2024-001670","article-title":"eHealth interventions and patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis","volume":"12","author":"Zafar","year":"2025","journal-title":"BMJ Open Gastroenterol"},{"key":"2026082803500992000_13.1.e002471.109","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2025-001895","article-title":"Liver fibrosis with persistently normal alanine transaminase levels exhibits a distinct treatment response in MASLD","volume":"12","author":"Luo","year":"2025","journal-title":"BMJ Open Gastroenterol"},{"key":"2026082803500992000_13.1.e002471.110","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.241171","article-title":"Diagnostic accuracy of CT for the detection of hepatic steatosis: a systematic review and meta-analysis","volume":"313","author":"Haghshomar","year":"2024","journal-title":"Radiology"},{"key":"2026082803500992000_13.1.e002471.111","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/HEP.0000000000001608","article-title":"Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance","volume":"83","author":"Bansal","year":"2026","journal-title":"Hepatology"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2026-002471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:50:25Z","timestamp":1787914225000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2026-002471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,8,28]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bmjgast-2026-002471"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2026-002471","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}